This presentation explores the progress that has been made and the challenges ahead as cellular therapeutics strive to mature in the...
Read moreResources
Cell Therapies Come of Age: Overcoming Challenges Within the Regulatory Framework
By Tracy TreDenick, Head of Regulatory and Quality Assurance, BioTechLogic While the field of stem cell therapy has been in development for decades, most notably with the...
BioTechLogic Perspectives on Oligonucleotide Therapies
Recently, I sat down with Tracy TreDenick, BioTechLogic’s Head of Regulatory and Quality Assurance, to learn more about her insights and experiences from the extensive...
CRISPR-CAS9: 101 Overview
This CRISPR-CAS9 inforgraphic is a wonderful overview for those familiarizing themselves with work going on within the genetic engineering space – hope you find it...
Stem Cell Market – Stem Cell–Based Products Aren’t Rolling Off Assembly Lines Yet
According to one forecast, the stem cell market will grow at an annual rate of 9.2% and attain a value of almost $16 billion by 2025. This prediction, from a 2017...
Best of CRISPR 2017 Articles
One can hardly pick up a science journal or biotech magazine without reading about another CRISPR-related advance. In the past six months, we have seen major advances in...
Recent Posts
- Top 25 Biotech Companies of 2024
- The EU Clinical Trials Regulation – Experiences from the First 18 Months
- CMC Expertise Accelerating Biologics Development for 20 Years and Counting
- Strengthening Your Gene Therapy Process Control Strategy
- Designing a Gene Therapy CMC Architecture for the Full Product Lifecycle